All questionsClinical trials: Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications2 questions · 2 sourcesInterpreting study resultsHow is Gardasil 9 related to Gardasil?“Efficacy and effectiveness of GARDASIL are relevant to GARDASIL 9 since the vaccines are manufactured similarly and contain 4 of the same HPV L1 VLPs.” (opens the source at this quote in a new tab)CopyFlag“The safety profile of GARDASIL 9 and GARDASIL are similar. The postmarketing safety experience with GARDASIL is relevant to GARDASIL 9 since the vaccines are manufactured similarly and contain the same L1 HPV proteins of four of the same HPV types.” (opens the source at this quote in a new tab)CopyFlagStudy resultsWhat percentage of people develop antibodies after Gardasil 9?“Across all clinical trials, at least 99.2% of individuals included in the analyses for each of the nine vaccine HPV types became seropositive by Month 7.” (opens the source at this quote in a new tab)CopyFlag“The minimum anti-HPV titer that confers protective efficacy has not been determined.” (opens the source at this quote in a new tab)CopyFlag